Monthly roundup · Biotech · August 2026
Biotech startup funding, August 2026: AusperBio Therapeutics's $120M Series C leads 11 rounds
We read 11 equity rounds in Biotech announced in August 2026, raising $467M between them: 5% of all the rounds we read that month and 2% of the money. The largest was AusperBio Therapeutics's $120M Series C, led by Harbert Growth Partners. The median seed round was $9.6M, against $6.7M over the last twelve months in Biotech; at Series A it was $40M. Highland Europe led the most rounds, with 2.
The biggest rounds
- 1AAusperBio TherapeuticsSeries C · United States · led by Harbert Growth Partners$120M
- 2
InfinimmuneSeries A · United States · led by Playground Global, Regeneron Ventures$75M - 3
Redx PharmaSeries A · United Kingdom$59M - 4KKhartis TherapeuticsSeries B · United States · led by Forge Life Science Partners$50M
- 5
AdaptyvSeries A · United Kingdom · led by Highland Europe$40M - 6AAdapyv BioSeries A · Switzerland · led by Highland Europe$40M
- 7CCraifSeries D · Japan · led by Granite-Integral, Tauns Co$33M
- 8
Dash BioSeries A · United States · led by Oak HC/FT$30M - 9NNybroSeed · Australia$14M
- 10IImmunobiota TherapeuticsSeed · Australia$5.0M
United States · led by Harbert Growth Partners
United Kingdom
Switzerland · led by Highland Europe
Japan · led by Granite-Integral, Tauns Co
AustraliaDay by day
Equity rounds in Biotech announced each day of August. The busiest day was 27 August, with 3.
By stage, against the year
Each stage's median this month beside its twelve-month median: the sector's own where we hold enough rounds for a benchmark, otherwise the one across all sectors.
The most active leads
Firms that led two or more of the month's rounds in Biotech.
Where
- United States4
- Australia2
- United Kingdom2
- Switzerland1
- Japan1
- Vietnam1
VietnamUnited States had the most Biotech rounds this month.
Against the month
- Rounds, Biotech11
- Rounds, all sectors220
- Raised, Biotech$467M
- Raised, all sectors$25B